Zombie patents — they cost the healthcare system billions, but just won’t die

I’ve been generally unsympathetic to cries that biotech and medical-device companies will suffer if U.S. patent law is reformed, and that has a lot to do with some of the grotesque patent abuses biopharma companies have perpetrated — quite legally — over the years in order to lock out competition for... (Read more)